Epidemiological studies had shown that increased heart rate was an independent risk factor for cardio-vascular disease risk and death,and an independent risk factor for hypertension and death.Effective heart rate control(measures and goals)is expected to bring significant benefits to hypertensive patients.However,using β receptor blockers that lower heart rate had not resulted in additional benefits for hypertensive patients.This clinical paradox deserves needs to further exploration.